Alumis, Inc. (ALMS)
5.60
-0.53
(-8.65%)
USD |
NASDAQ |
Nov 13, 16:00
5.55
-0.05
(-0.89%)
After-Hours: 19:59
Alumis Total Assets (Quarterly) : 488.71M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 488.71M |
| June 30, 2026 | 560.62M |
| March 31, 2026 | 671.59M |
| December 31, 2025 | 416.14M |
| September 30, 2025 | 488.01M |
| June 30, 2025 | 610.92M |
| Date | Value |
|---|---|
| March 31, 2025 | 261.30M |
| December 31, 2024 | 340.99M |
| September 30, 2024 | 412.56M |
| June 30, 2024 | 265.18M |
| March 31, 2024 | 177.38M |
| December 31, 2023 | 89.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 197.42B |
| BioAge Labs, Inc. | 367.65M |
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 110.29M |
| Shareholders Equity (Quarterly) | 378.42M |
| Debt to Equity Ratio | 0.0933 |
| Current Ratio | 5.574 |
| Net Debt Paydown Yield | 0.07% |